Bilateral subthalamic nucleus deep brain stimulation for dopa-responsive dystonia in a 6-year-old child

Case report

Restricted access

Tyrosine hydroxylase (TH) deficiency is a rare autosomal recessive metabolic disease that results in the decreased production of catecholamines. Standard treatment relies on combinations of levodopa and carbidopa, anticholinergic agents, serotonergic agonists, and monamine oxidase B inhibitors. Unfortunately, severely affected children often require escalating doses of medication and suffer from dyskinesias as well as significant on/off symptomatology.

The authors present a case of medically intractable dopa-responsive dystonia in a 6-year-old boy whose condition significantly improved with bilateral subthalamic nucleus deep brain stimulation. This case is unique in its novel approach to tyrosine hydroxylase deficiency and the young age of the patient.

Abbreviations used in this paper: DBS = deep brain stimulation; DRD = dopa-responsive dystonia; MER = microelectrode recording; STN = subthalamic nucleus; TH = tyrosine hydroxylase.

Article Information

Address correspondence to: Elizabeth C. Tyler-Kabara, M.D., Ph.D., Department of Neurological Surgery, Division of Pediatric Neurosurgery, 4401 Penn Avenue, Pittsburgh, Pennsylvania 15224. email: Elizabeth.tyler-kabara@chp.edu.

© AANS, except where prohibited by US copyright law.

Headings

Figures

References

1

Alterman RLTagliati M: Deep brain stimulation for torsion dystonia in children. Childs Nerv Syst 23:103310402007

2

Benabid AL: Deep brain stimulation for Parkinson's disease. Curr Opin Neurobiol 13:6967062003

3

Bergman HWichmann TDeLong MR: Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249:143614381990

4

Deep-Brain Stimulation for Parkinson's Disease Study Group: Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 345:9569632001

5

Gubellini PEusebio AOueslati AMelon CKerkerian-Le Goff LSalin P: Chronic high-frequency stimulation of the subthalamic nucleus and L-DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission. Eur J Neurosci 24:180218142006

6

Henderson JMDunnett SB: Targeting the subthalamic nucleus in the treatment of Parkinson's disease. Brain Res Bull 46:4674741998

7

Hilker RVoges JGhaemi MLehrke RRudolf JKoulousakis A: Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans. Mov Disord 18:41482003

8

Houeto JLDamier PBejjani PBStaedler CBonnet AMArnulf I: Subthalamic stimulation in Parkinson disease: a multidisciplinary approach. Arch Neurol 57:4614652000

9

Jankovic JTintner R: Dystonia and parkinsonism. Parkinsonism Relat Disord 8:1091212001

10

Kumar RLozano AMKim YJHutchison WDSime EHalket E: Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 51:8508551998

11

Kumar RLozano AMMontgomery ELang AE: Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease. Mov Disord 13:Suppl 173821998

12

Lee KHChang SYRoberts DWKim U: Neurotransmitter release from high-frequency stimulation of the subthalamic nucleus. J Neurosurg 101:5115172004

13

Marks WAHoneycutt JAcosta FReed M: Deep brain stimulation for pediatric movement disorders. Semin Pediatr Neurol 16:90982009

14

Moro ELozano AMPollak PAgid YRehncrona SVolkmann J: Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord 25:5785862010

15

Nakajima TNimura TYamaguchi KAndo TItoh MYoshimoto T: The impact of stereotactic pallidal surgery on the dopamine D2 receptor in Parkinson disease: a positron emission tomography study. J Neurosurg 98:57632003

16

Nimura TYamaguchi KAndo TShibuya SOikawa TNakagawa A: Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study. J Neurosurg 103:9689732005

17

Østergaard KSunde NDupont E: Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations. Mov Disord 17:6937002002

18

Poewe WHLees AJStern GM: Dystonia in Parkinson's disease: clinical and pharmacological features. Ann Neurol 23:73781988

19

Schiller AWevers RASteenbergen GCBlau NJung HH: Long-term course of L-dopa-responsive dystonia caused by tyrosine hydroxylase deficiency. Neurology 63:152415262004

20

Shon YMLee KHGoerss SJKim IYKimble CVan Gompel JJ: High frequency stimulation of the subthalamic nucleus evokes striatal dopamine release in a large animal model of human DBS neurosurgery. Neurosci Lett 475:1361402010

21

Sterio DRezai AMogilner AZonenshayn MGracies JMKathirithamby K: Neurophysiological modulation of the subthalamic nucleus by pallidal stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry 72:3253282002

22

Strafella APSadikot AFDagher A: Subthalamic deep brain stimulation does not induce striatal dopamine release in Parkinson's disease. Neuroreport 14:128712892003

23

Tolosa ECompta Y: Dystonia in Parkinson's disease. J Neurol 253:Suppl 7VII7VII132006

24

Vlamings RVisser-Vandewalle VKozan RKaplan SSteinbusch HWTemel Y: Bilateral high frequency stimulation of the subthalamic nucleus normalizes COX activity in the substantia nigra of Parkinsonian rats. Brain Res 1288:1431482009

25

Weaver FMFollett KStern MHur KHarris CMarks WJ Jr: Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 301:63732009

26

Williams AGill SVarma TJenkinson CQuinn NMitchell R: Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol 9:5815912010

27

Zhao XDCao YQLiu HHLi FQYou BMZhou XP: Long term high frequency stimulation of STN increases dopamine in the corpus striatum of hemiparkinsonian rhesus monkey. Brain Res 1286:2302382009

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 48 48 19
Full Text Views 58 58 12
PDF Downloads 37 37 3
EPUB Downloads 0 0 0

PubMed

Google Scholar